Gracell Biotechnologies (GRCL) Q4 2020 Earnings

9MarConfirmed
Jan 21
Q4 2020
-0.26
-0.21
-0.15
-0.1

Details

Expected EPS
-0.1
Actual EPS
-0.16
Surprise EPS
-0.06
Surprise Percent
+60%

Description

Gracell Biotechnologies (GRCL) has reported earnings of -0.16 per share for Q4 2020.

0 Comments

Share your thoughts